The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 1, 2026 → Nov 10, 2026
See other at-risk trials from Vivek Narayan

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Primary completion pushed from Aug 1, 2026 to Nov 10, 2026
    • Study completion pushed from Aug 1, 2026 to Jan 1, 2027
    • Secondary endpoints: details revised at 2 of 6 entries
    • Site details revised
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Jun 30, 2025 to Aug 1, 2026
    • Study completion date: Jun 30, 2026 to Aug 1, 2026
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 23, 2023 to Nov 14, 2023
    v3
  5. Start date: Oct 6, 2023 to Oct 23, 2023v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vivek Narayan
1 trial monitored
See 1 trial at risk
Prostate Cancer
2,550 trials monitored
See 165 trials at risk
The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations. The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer. The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.
Trial Details
NCT Number NCT06064149
Lead Sponsor Vivek Narayan
Collaborators: National Comprehensive Cancer Network
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov